Psychobiological Mechanism of Resilience and Vulnerability: Implications for Successful Adaptation to Extreme Stress

American Journal of Psychiatry

Volumn 161, Issue 2, 2004, Pages 195-216

  Charney, Dennis S ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE RECEPTOR; DOPAMINE; ESTROGEN; GALANIN; HYDROCORTISONE; NEUROPEPTIDE; NEUROPEPTIDE Y; NEUROTRANSMITTER; NORADRENALIN; PRASTERONE; SEROTONIN; TESTOSTERONE; 4 AMINOBUTYRIC ACID A RECEPTOR; CORTICOTROPIN RELEASING FACTOR;

ADAPTATION; BEHAVIOR; CONDITIONING; DISEASE ACTIVITY; FEAR; HUMAN; MENTAL DISEASE; MENTAL STRESS; MODEL; MOTIVATION; NEUROBIOLOGY; NONHUMAN; PRIORITY JOURNAL; PSYCHOBIOLOGY; REVIEW; REWARD; SOCIAL ASPECT; SOCIAL BEHAVIOR; ADAPTIVE BEHAVIOR; ANIMAL; BRAIN; HISTOLOGY; HOSPITALIZATION; LOCUS CERULEUS; METABOLISM; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; REINFORCEMENT;

ADAPTATION, PSYCHOLOGICAL; ANIMALS; BRAIN; CONDITIONING (PSYCHOLOGY); CORTICOTROPIN-RELEASING HORMONE; DOPAMINE; ESTROGENS; EXTINCTION, PSYCHOLOGICAL; FEAR; GALANIN; HUMANS; HYDROCORTISONE; LOCUS COERULEUS; NEUROPEPTIDE Y; NOREPINEPHRINE; RECEPTORS, GABA-A; REWARD; SEROTONIN; SEVERITY OF ILLNESS INDEX; SOCIAL BEHAVIOR; STRESS, PSYCHOLOGICAL; TESTOSTERONE;

EID: 1642487147     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.161.2.195     Document Type: Review

References (219)

1. Sterling P, Eyer J: Allostasis: a new paradigm to explain arousal pathology, in Handbook of Life Stress, Cognition, and Health. Edited by Fisher S, Reason J. New York, John Wiley & Sons, 1988, pp 629-649
2. McEwen BS: Sex, stress, and the hippocampus: allostasis, allostatic load and the aging process. Neurobiol Aging 2002; 23: 921-939
3. McEwen BS, Stellar E: Stress and the individual: mechanisms leading to disease. Arch Intern Med 1993; 153:2093-2101
4. Gold PW, Drevets WC, Charney DS: New insights into the role of cortisol and the glucocorticoid receptor in severe depression. Biol Psychiatry 2002; 52:381-385
5. Makino S, Gold PW, Schulkin J: Effects of corticosterone on CRH mRNA and content in the bed nucleus of the stria terminalis; comparison with the effects in the central nucleus of the amygdala and the paraventricular nucleus of the hypothalamus. Brain Res 1994; 675:141-149
6. Makino S, Gold PW, Schulkin J: Corticosterone effects on corticotropin-releasing hormone mRNA in the central nucleus of the amygdala and the parvocellular region of the paraventricular nucleus of the hypothalamus. Brain Res 1994; 640:105-112
7. Shepard JD, Barron KW, Myers DA: Corticosterone delivery to the amygdala increases corticotropin-releasing factor mRNA in the central amygdaloid nucleus and anxiety-like behavior. Brain Res 2000; 861:288-295
8. Lee Y, Schulkin J, Davis M: Effect of corticosterone on the enhancement of the acoustic startle reflex by corticotropin releasing factor (CRF). Brain Res 1994; 666:93-98
9. Roozendaal B: Glucocorticoids and the regulation of memory consolidation. Psychoneuroendocrinology 2000; 25:213-238
10. Diamond DM, Fleshner M, Ingersoll N, Rose GM: Psychological stress impairs spatial working memory: relevance to electrophysiological studies of hippocampal function. Behav Neurosci 1996; 110:661-672
11. Karlamangla AS, Singer BH, McEwen BS, Rowe JW, Seeman TE: Allostatic load as a predictor of functional decline: MacArthur studies of successful aging. J Clin Epidemiol 2002; 55:696-710
12. Rosenfeld RS, Hellman L, Roffwarg H, Weitzman ED, Fukushima DK, Gallagher TF: Dehydroisoandrosterone is secreted episodically and synchronously with cortisol by normal man. J Clin Endocrinol Metab 1971; 33:87-92
13. Browne ES, Wright BE, Porter JR, Svec F: Dehydroepiandrosterone: antiglucocorticoid action in mice. Am J Med Sci 1992; 303: 366-371
14. Rose KA, Stapleton G, Dott K, Kieny MP, Best R, Schwarz M, Russell DW, Bjorkheim I, Seckl J, Lathe R: Cyp7b, a novel brain cytochrome P450, catalyzes the synthesis of neurosteroids 7alpha-hydroxy dehydroepiandrosterone and 7alpha-hydroxy pregnenolone. Proc Natl Acad Sci USA 1997; 94:4925-4930
15. Morfin R, Starka L: Neurosteroid 7-hydroxylation products in the brain. Int Rev Neurobiol 2001; 46:79-95
16. Kimonides VG, Khatibi NH, Svendsen CN, Sofroniew MV, Herbert J: Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity. Proc Natl Acad Sci USA 1998; 95: 1852-1857
17. Bastianetto S, Ramassamy C, Poirier J, Quirion R: Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage. Brain Res Mol Brain Res 1999; 66: 35-41
18. Kaminska M, Harris J, Gilsbers K, Dubrovsky B: Dehydroepiandrosterone sulfate (DHEAS) counteracts decremental effects of corticosterone on dentate gyrus LTP: implications for depression. Brain Res Bull 2000; 52:229-234
19. Goodyer IM, Herbert J, Altham PME: Adrenal steroid secretion and major depression in 8- to 16-year-olds, III: influence of cortisol/DHEA ratio at presentation on subsequent rates of disappointing life events and persistent major depression. Psychol Med 1998; 28:265-273
20. Goodyer IM, Park RJ, Netherton CM, Herberg J: Possible role of cortisol and dehydroepiandrosterone in human development and psychopathology. Br J Psychiatry 2001; 179:243-249
21. Young AH, Gallagher P, Porter RJ: Elevation of the cortisol-dehydroepiandrosterone ratio in drug-free depressed patients. Am J Psychiatry 2002; 159:1237-1239
22. Wolkowitz OM, Reus VI, Keebler A, Nelson N, Friedland M, Brizendine L, Roberts E: Double-blind treatment of major depression with dehydroepiandrosterone. Am J Psychiatry 1999; 156: 646-649
23. A receptor: mechanism of action and physiological significance. Prog Neurobiol 1992; 38:379-395
24. Bergeron R, de Montigny C, Debonnel G: Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated by sigma receptors. J Neurosci 1996; 16:1193-1202
25. Grammatopoulos DK, Chrousos GP: Functional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonists. Trends Endocrinol Metab 2002; 13:436-444
26. Steckler T, Holsboer F: Corticotropin-releasing hormone receptor subtypes and emotion. Biol Psychiatry 1999; 46:1480-1508
27. Strome EM, Trevor GHW, Higley JD, Liriaux DL, Suomi SJ, Doudet DJ: Intracerebroventricular corticotropin-releasing factor increased limbic glucose metabolism and has social context dependent behavioral effects in nonhuman primates. Proc Natl Acad Sci USA 2002; 99:15749-15754
28. Nemeroff CB: Recent advances in the neurobiology of depression. Psychopharmacol Bull 2002; 36:6-23
29. Bremner JD, Licinio J, Darnell A, Krystal JH, Owens MJ, Southwick SM, Nemeroff CB, Charney DS: Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder. Am J Psychiatry 1997; 154:624-629
30. Baker DG, West SA, Nicholson WE, Ekhator NN, Kasckow JW, Hill KK, Bruce AB, Orth DN, Geracioti TD Jr: Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder. Am J Psychiatry 1999; 156:585-588; correction, 156:986
31. Sanchez MM, Young LJ, Plotsky PM, Insel TR: Autoradiographic and in situ hybridization localization of corticotropin-releasing factor 1 and 2 receptors in nonhuman primate brain. J Comp Neurol 1999; 408:365-377
32. Bale TL, Picetti R, Contarino A, Koob GF, Vale WW, Kuo-Fen L: Mice deficient for both corticotropin-releasing factor receptor 1 (CRFR1) and CRFR2 have an impaired stress response and display sexually dichotomous anxiety-like behavior. J Neurosci 2002; 22:193-199
33. Bale TL, Contarino A, Smith GW, Chan R, Gold LH, Sawchenko PE, Koob GF, Vale WW, Lee KF: Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behavior and are hypersensitive to stress. Nat Genet 2000; 24:410-414
34. Coste SC, Kesterson RA, Heldwein KA, Stevens SL, Heard AD, Hollis JH, Murray SE, Hill JK, Pantely GA, Hohimer AR, Hatton DC, Phillips TJ, Finn DA, Low MJ, Rittenberg MB, Stenzel P, Stenzel-Poore MP: Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. Nat Genet 2000; 24:403-409
35. Charney DS, Bremner JD: The neurobiology of anxiety disorders, in Neurobiology of Mental Illness. Edited by Charney DS, Nestler EJ, Bunney BS. New York, Oxford University Press, 1999, pp 494-517
36. Charney DS, Woods SW, Goodman WK, Heninger GR: Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks. Am J Psychiatry 1987; 144:1030-1036
37. Charney DS, Woods SW, Krystal JH, Nagy LM, Heninger GR: Noradrenergic neuronal dysregulation in panic disorder: the effects of intravenous yohimbine and clonidine in panic disorder patients. Acta Psychiatr Scand 1992; 86:273-282
38. Geracioti TD Jr, Baker DG, Ekhator NN, West SA, Hill KK, Bruce AB, Schmidt D, Rounds-Kugler B, Yehuda R, Keck PE Jr, Kasckow JW: CSF norepinephrine concentrations in posttraumatic stress disorder. Am J Psychiatry 2001; 158:1227-1230
39. Southwick SM, Krystal JH, Bremner JD, Morgan CA, Nicolaou AL, Nagy LM, Johnson DR, Heninger GR, Charney DS: Noradrenergic and serotonergic function in posttraumatic stress disorder. Arch Gen Psychiatry 1997; 4:749-758
40. Wong ML, Kling MA, Munson PJ, Listwak S, Licinio J, Prolo P, Karp B, McCutcheon IE, Geracioti TD Jr, DeBellis MD, Rice KC, Goldstein DS, Veldhuis JD, Chrousos GP, Oldfield EH, McCann SM, Gold PW: Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. Proc Natl Acad Sci USA 2000; 97:325-330
41. Makino S, Baker RA, Smith MA, Gold PW: Differential regulation of neuropeptide Y mRNA expression in the accurate nucleus and locus coeruleus by stress and antidepressants. J Neuroendocrinol 2000; 12:387-395
42. Baker RA, Herkenham M: Arcuate nucleus neurons that project to the hypothalamic paraventricular nucleus: neuropeptidergic identity and consequences of adrenalectomy on mRNA levels in the rat. J Comp Neurol 1995; 358:518-530
43. Risold PY, Swanson LW: Chemoarchitecture of the rat lateral septal nucleus. Brain Res Brain Res Rev 1997; 24:91-113
44. Pieribone VA, Brodin L, Friberg K, Dahlstrand J, Soderberg C, Larhammar D, Hokfelt T: Differential expression of mRNAs for neuropeptide Y-related peptides in rat nervous tissues: possible evolutionary conservation. J Neurosci 1992; 12:3361-3371
45. Allen YS, Adrian TE, Allen JM, Tatemoto K, Crow TJ, Bloom SR, Polak JM: Neuropeptide Y distribution in the rat brain. Science 1983; 221:877-879
46. Heilig M, McLeod S, Brot M, Heinrichs SC, Menzaghi F, Koob GF, Britton KT: Anxiolytic-like action of neuropeptide Y: mediation by Y1 receptors in amygdala, and dissociation from food intake effects. Neuropsychopharmacology 1993; 8:357-363
47. Heilig M: Antisense inhibition of neuropeptide Y (NPY)-Y1 receptor expression blocks the anxiolytic-like action of NPY in amygdala and paradoxically increases feeding. Regul Pept 1995; 59:201-205
48. Sajdyk TJ, Vandergriff MG, Gehlert DR: Amygdalar neuropeptide Y Y1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test. Eur J Pharmacol 1999; 368:143-147
49. Thorsell A, Carlsson K, Ekman R, Heilig M: Behavioral and endocrine adaptation, and up-regulation of NPY expression in rat amygdala following repeated restraint stress. Neuroreport 1999; 10:3003-3007
50. Flood JF, Baker ML, Hernandez EN, Morley JE: Modulation of memory processing by neuropeptide Y varies with brain injection site. Brain Res 1989; 503:73-82
51. Illes P, Finta EP, Nieber K: Neuropeptide Y potentiates via Y2-receptors the inhibitory effect of noradrenaline in rat locus coeruleus neurons. Naunyn Schmiedebergs Arch Pharmacol 1993; 348:546-548
52. Thorsell A, Michalkiewicz M, Dumont Y, Quirion R, Caberlotto L, Rimondini R, Mathe AA, Helig M: Behavioral insensitivity to restraint stress, absent fear suppression of behavior, and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression. Proc Natl Acad Sci USA 2000; 97:12852-12857
53. Britton KT, Akwa Y, Spina MG, Koob GF: Neuropeptide Y blocks anxiogenic-like behavioral action of corticotropin-releasing factor in an operant conflict test and elevated plus maze. Peptides 2000; 21:37-44
54. Heilig M, Koob GF, Ekman R, Britton KT: Corticotropin-releasing factor and neuropeptide Y: role in emotional integration. Trends Neurosci 1994; 17:80-85
55. Kask A, Rago L, Harro J: Alpha-helical CRF(9-41) prevents anxiogenic-like effect on NPY Y1 receptor antagonist BIBP3226 in rats. Neuroreport 1997; 8:3645-3647
56. Kask A, Harro J, von Horsten S, Redrobe JP, Dumont Y, Quiron R: The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y. Neurosci Behav Rev 2002; 26:259-283
57. Smagin GN, Harris RB, Ryan DH: Corticotropin-releasing factor receptor antagonist infused into the locus coeruleus attenuates immobilization stress-induced defensive withdrawal in rats. Neurosci Lett 1996; 220:167-170
58. Kask A, Rago L, Harro J: Naxiolytic-like effect of neuropeptide Y (NPY) and NPY 13-36 microinjected into vicinity of locus coeruleus in rats. Brain Res 1998; 788:345-348
59. Sheriff S, Dautzenberg FM, Mulchahey JJ, Pisarska M, Hauger RL, Chance WT, Balasubramaniam A, Kasckow JW: Interaction of neuropeptide Y and corticotropin-releasing factor signaling pathways in AR-5 amygdalar cells. Peptides 2001; 22:2083-2089
60. Sajdyk TJ, Schober DA, Gehlert DR, Shekhar A: Role of corticotropin-releasing factor and urocortin within the basolateral amygdala of rats in anxiety and panic responses. Behav Brain Res 1999; 100:207-215
61. Kask A, Rago L, Harro J: NPY Y1 receptors in the dorsal periaqueductal gray matter regulate anxiety in the social interaction test. Neuroreport 1998; 9:2713-2716
62. Martins AP, Maras RA, Guimaraes FS: Anxiolytic effect of a CRH receptor antagonist in the dorsal periaqueductal gray. Depress Anxiety 2001; 12:99-101
63. Morgan CA, Wang S Mason J, Southwick SM, Fox P, Hazlett G, Charney DS, Greenfield G: Hormone profiles in humans experiencing military survival training. Biol Psychiatry 2000; 47:891-901
64. Rasmusson AM, Hauger RI, Morgan CA, Bremner JD, Charney DS, Southwick SM: Low baseline and yohimbine-stimulated plasma neuropeptide Y (NPY) levels in combat-related PTSD. Biol Psychiatry 2000; 47:526-539
65. Mathe HH: Early life stress changes concentrations of neuropeptide Y and corticotropin-releasing hormone in adult rat brain: lithium treatment modifies these changes. Neuropsychopharmacology 2002; 27:756-764
66. Holmes A, Yang RJ, Crawley JN: Evaluation of an anxiety-related phenotype in galanin overexpressing transgenic mice. J Mol Neurosci 2002; 18:151-165
67. Holmes PV, Crawley JN: Coexisting neurotransmitters in central noradrenergic neurons, in Psychopharmacology: The Fourth Generation of Progress. Edited by Bloom FE, Kupfer DJ. New York, Raven Press, 1995, pp 347-353
68. Gentleman SM, Falkai P, Bogerts B, Herrero MT, Polak JM, Roberts GW: Distribution of galanin-like immunoreactivity in the human brain. Brain Res 1989; 505:311-315
69. Perez SE, Wynic D, Steiner RA, Mufson EJ: Distribution of galaninergic immunoreactivity in the brain of the mouse. J Comp Neurol 2001; 434:158-185
70. Sevcik J, Finta EP, Illes P: Galanin receptors inhibit the spontaneous firing of locus coeruleus neurons and interact with muopioid receptors. Eur J Pharmacol 1993; 230:223-230
71. Xu ZQ, Tong YG, Hokfelt T: Galanin enhances noradrenaline-induced outward current on locus coeruleus noradrenergic neurons. Neuroreport 2001; 12:1179-1182
72. Bing O, Moller C, Engel JA, Soderpal B, Heilig M: Anxiolytic-like action of centrally administered galanin. Neurosci Lett 1993; 164:17-20
73. Moller C, Sommer W, Thorsell A, Heilig M: Anxiogenic-like action of galanin after intra-amygdala administration in the rat. Neuropsychopharmacology 1999; 21:507-512
74. Khoshbouei H, Cecchi M, Dove S, Javors M, Morilak DA: Behavioral reactivity to stress: amplification of stress-induced noradrenergic activation elicits a galanin-mediated anxiolytic effect in central amygdala. Pharmacol Biochem Behav 2002; 71: 407-417
75. Kinney JW, Starosta G, Holmes A, Wrenn CC, Yang RJ, Harris AP, Long KC, Crawley JN: Deficits in trace cued fear conditioning in galanin-treated rats and galanin-overexpressing transgenic mice. Learn Mem 2002; 9:178-190
76. Gustafson EL, Smith KE, Durkin MM, Gerald C, Branchek TA: Distribution of a rat galanin receptor mRNA in rat brain. Neuroreport 1996; 7:953-957
77. Holmes A, Kinney JW, Wrenn CC, Li Q, Yang RJ, Ma L, Vishwanath J, Saavedra MC, Innerfield CE, Jacoby AS, Shine J, Iismaa TP, Crawley JN: Galanin GAL-R1 receptor null mutant mice display increased anxiety-like behavior specific to the elevated plus-maze. Neuropsychopharmacology 2003; 28:1931-1044
78. Hokfelt T, Millhorn D, Seroogy K, Seroogy K, Tsuruo Y, Ceccatelli S, Lindh B, Meister B, Melander T, Schalling M, Bartfai T, et al: Coexistence of peptides with classical transmitters. Experientia 1987; 43:768-780
79. Consolo S, Baldi G, Russi G, Civenni G, Bartfai T, Vezzani A: Impulse flow dependency of galanin release in vivo in the rat ventral hippocampus. Proc Natl Acad Sci USA 1994; 91:8047-8051
80. Ventura R, Cabib S, Puglisi-Allegra S: Genetic susceptibility of mesocortical dopamine to stress determines liability to inhibition of mesoaccumbens dopamine and to behavioral despair in a mouse model of depression. Neuroscience 2002; 115:99-1007
81. Cabib S, Puglisi-Allegra S: Different effects of repeated stressful experiences on mesocortical and mesolimbic dopamine metabolism. Neuroscience 1996; 73:375-380
82. Cabib S, Ventgura R, Puglisi-Allegra S: Opposite imbalances between mesocortical and mesoaccumbens dopamine responses to stress by the same genotype depending on living conditions. Behav Brain Res 2002; 129:179-185
83. Goldstein LE, Rasmusson AM, Bunney BS, Roth RH: Role of the amygdala in the coordination of behavioral, neuroendocrine, and prefrontal cortical monoamine responses to psychological stress in the rat. J Neurosci 1996; 16:4787-4798
84. Morrow BA, Elsworth JD, Rasmusson AM, Roth RH: The role of mesoprefrontal dopamine neurons in the acquisition and expression of conditioned fear in the rat. Neuroscience 1999; 92: 553-564
85. Lemieux AM, Coe CL: Abuse-related PTSD: evidence for chronic neuroendocrine activation in women. Psychosom Med 1995; 57:105-115
86. Hamner MB, Diamond BI: Elevated plasma dopamine in posttraumatic stress disorder: a preliminary report. Biol Psychiatry 1993; 33:304-306
87. Lambert G, Johansson M, Agren H, Friberg P: Reduced brain norepinephrine and dopamine release in treatment refractory depressive illness. Arch Gen Psychiatry 2000; 57:787-793
88. Kent JM, Mathew SJ, Gorman JM: Molecular targets in the treatment of anxiety. Biol Psychiatry 2002; 52:1008-1030
89. Charney DS, Drevets WD: Neurobiological basis of anxiety disorders, in Neuropsychopharmacology: The Fifth Generation of Progress. Edited by Davis KL, Charney D, Coyle JT, Nemeroff C. Philadelphia, Lippincott Williams & Wilkins, 2002
90. Pazos A, Probst A, Palacios J: Serotonin receptors in the human brain, III: autoradiographic mapping of serotonin-1 receptors. Neuroscience 1987; 21:97-122
91. Hamon M, Gozlan H, el Mestikawy S, Emerit MB, Bolanos F, Schechter L: The central 5-HT1A receptors: pharmacological, biochemical, functional, and regulatory properties. Ann NY Acad Sci 1990; 600:114-129
92. Heisler LK, Chu H-M, Brennan TJ, Danao JA, Bajwa P, Parsons LH, Tecott LH: Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. Proc Natl Acad Sci USA 1998; 95:15049-15054
93. Parks C, Robinson P, Sibille E, Shenk T, Toth M: Increased anxiety of mice lacking the serotonin 1A receptor. Proc Natl Acad Sci USA 1998; 95:10734-10739
94. Gross C, Zhuang X, Stark K, Ramboz S, Oosting R, Kirby L, Santarelli L, Beck S, Hen R: Serotonin 1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature 2002; 416:396-400
95. Lopez JF, Chalmers DT, Little KY, Watson SJ: AE Bennett Research Award: regulation of serotonin1a, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression. Biol Psychiatry 1998; 43:547-573
96. Sibille E, Pavlides C, Benke D, Toth M: Genetic inactivation of the serotonin(1A) receptor in mice results in downregulation of major GABA(A) receptor alpha subunits, reduction of GABA(A) receptor binding, and benzodiazepine-resistant anxiety. J Neurosci 2000; 20:2758-2765
97. Pattij T, Groenink L, Oosting RS, van der Gugten J, Maes RAA, Olivier B: GABA(A)-benzodiazepine receptor complex sensitivity in 5-HT(1A) receptor knockout mice on a 129/Sv background. Eur J Pharmacol 2002; 447:67-74
98. Drevets WC, Frank JC, Kupfer DJ, Holt D, Greer PJ, Huang Y, Gautier C, Mathis C: PET imaging of serotonin 1A receptor binding in depression. Biol Psychiatry 1999; 46:1375-1387
99. Neumeister A, Bain E, Nugent AC, Carson RE, Bonne O, Luckenbaugh DA, Eckelman W, Herscovitch P, Charney DS, Drevets W: Reduced serotonin type 1A receptor binding in panic disorder. J Neurosci (in press)
100. Weizman R, Weizman A, Kook KA, Vocci F, Deutsch S, Paul SM: Repeated swim stress alters brain benzodiazepine receptors measured in vivo. J Pharmacol Exp Ther 1989; 249:701-707
101. Nutt DJ, Malizia AL: New insights into the role of the GABA(A)-benzodiazepine receptor in psychiatric disorder. Br J Psychiatry 2001; 179:390-396
102. Malizia AL, Cunningham VJ, Bell CJ, Liddle PF, Jones T, Nutt DJ: Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study. Arch Gen Psychiatry 1998; 55:715-720
103. Bremner JD, Innis RB, White T, Fujita M, Silbersweig D, Goddard AW, Staib L, Stern E, Cappiello A, Woods S, Baldwin R, Charney DS: SPECT [I-123]iomazenil measurement of the benzodiazepine receptor in panic disorder. Biol Psychiatry 2000; 47:96-106
104. Bremner JD, Innis RB, Southwick SM, Staib L, Zoghbi S, Charney DS: Decreased benzodiazepine receptor binding in prefrontal cortex in combat-related posttraumatic stress disorder. Am J Psychiatry 2000; 157:1120-1126
105. Zitzmann M, Nieschlag E: Testosterone levels in healthy men and the relation to behavioural and physical characteristics: facts and constructs. Eur J Endocrinol 2001; 144:183-187
106. Flugge G, Kramer M, Fuchs E: Chronic subordination stress in male tree shrews: replacement of testosterone affects behavior and central alpha2-adrenoceptors. Physiol Behav 2001; 73: 293-300
107. Schaal B, Tremblay RE, Soussignan R, Susman EJ: Male testosterone linked to high social dominance but low physical aggression in early adolescence. J Am Acad Child Adolesc Psychiatry 1996; 35:1322-1330
108. Suay F, Salvador A, Gonzalez-Bono E, Sanchis C, Martinez M, Martinez-Sanchis S, Simon VM, Montoro JB: Effects of competition and its outcome on serum testosterone, cortisol and prolactin. Psychoneuroendocrinology 1999; 24:551-566
109. Brooks JH, Reddon JR: Serum testosterone in violent and non-violent young offenders. J Clin Psychol 1996; 52:475-485
110. Banks T, Dabbs JM Jr: Salivary testosterone and cortisol in a delinquent and violent urban subculture. J Soc Psychol 1996; 136:49-56
111. Aromaki AS, Lindman RE, Eriksson CJP: Testosterone aggressiveness and antisocial personality. Aggressive Behavior 1999; 25:113-123
112. Lee S, Miselis R, Rivier C: Anatomical and functional evidence for a neural hypothalamic-testicular pathway that is independent of the pituitary. Endocrinology 2002; 143:4447-4454
113. Mulchahey JJ, Ekhator NN, Zhang H, Kasckow JW, Baker DG, Geracioti TD Jr: Cerebrospinal fluid and plasma testosterone levels in post-traumatic stress disorder and tobacco dependence. Psychoneuroendocrinology 2001; 26:273-285
114. Bauer M, Priebe S, Graef KJ, Keurten I: Psychosocial and endocrine abnormalities in refugees from East Germany, II: serum levels of cortisol, prolactin, luteinizing hormone, follicle stimulating hormone and testosterone. Psychiatry Res 1994; 51:75-85
115. Pope HG Jr, Cohane GH, Kanayama G, Siegel AJ, Hudson JI: Testosterone gel supplementation for men with refractory depression: a randomized, placebo-controlled trial. Am J Psychiatry 2003; 160:105-111
116. Wang C, Alexander G, Berman N, Salehian B, Davidson T, McDonald V, Steiner B, Hull L, Callegari C, Swerdloff RS: Testosterone replacement therapy improves mood in hypogonadal men - a clinical research center study. J Clin Endocrinol Metab 1996; 81:3578-3583
117. Stroud LR, Salovey P, Epel ES: Sex differences in stress responses: social rejection versus achievement stress. Biol Psychiatry 2002; 52:318-327
118. Young EA, Altemus M, Parkison V, Shastry S: Effects of estrogen antagonists and agonists on the ACTH response to restraint stress in female rats. Neuropsychopharmacology 2001; 25: 881-891
119. Carey MP, Deterd CH, deKoning J, Helmerhorst F, de Kloet ER: The influence of ovarian steroids on hypothalamic-pituitary-adrenal regulation in the female rat. J Endocrinol 1995; 144: 311-321
120. Young EA: Sex differences in response to exogenous corticosterone. Mol Psychiatry 1996; 1:313-319
121. Komesaroff PA, Esler MD, Sudhir K: Estrogen supplementation attenuates glucocorticoid and catecholamine responses to mental stress in perimenopausal women. J Clin Endocrinol Metab 1999; 84:606-610
122. Cucinelli F, Soranna L, Barini A, Perri C, Leoni F, Mancuso S, Lanzone A: Estrogen treatment and body fat distribution are involved in corticotropin and cortisol response to corticotropin-releasing hormone in postmenopausal women. Metabolism 2002; 51:137-143
123. Biller BM, Federoff JH, Loenig JL, Klibanski A: Abnormal cortisol secretion and responses to corticotropin-releasing hormone in women with hypothalamic amenorrhea. J Clin Endocrinol Metab 1990; 70:311-317
124. Patchev VK, Hayashi S, Orikasa C, Almeida OF: Implications of estrogen-dependent brain organization for gender differences in hypothalamo-pituitary-adrenal regulation. FASEB J 1995; 9: 419-423
125. Hamlet MA, Rorie DK, Tyce GM: Effects of estradiol on release and disposition of norepinephrine from nerve endings. Am J Physiol 1980; 239:H450-H456
126. Colucci WS, Gimbrone MA, McLaughlin MK, Halpern W, Alexander RW: Increased vascular catecholamine sensitivity and alpha-adrenergic receptor affinity in female and estrogen-treated male rats. Circ Res 1982; 50:805-811
127. Klangkalya B, Chan A: The effects of ovarian hormones on β-adrenergic and muscarinic receptors in rat heart. Life Sci 1988; 42:2307-2314
128. Maggi A, Perez J: Estrogen-induced up-regulation of gamma-amino butyric receptors in the CNS of rodents. J Neurochem 1986; 47:1793-1797
129. McEwen B: Estrogen actions throughout the brain. Recent Prog Horm Res 2002; 57:357-384
130. Bethea CL, Mirkes SJ, Shively CA, Adams MR: Steroid regulation of tryptophan hydroxylase protein in the dorsal raphe of macaques. Biol Psychiatry 2000; 47:562-576
131. Pecins-Thompson M, Brown NA, Bethea CL: Regulation of serotonin re-uptake transporter mRNA expression by ovarian steroids in rhesus macaques. Mol Brain Res 1998; 53:120-129
132. Moses EL, Drevets WC, Smith G, Mathis CA, Kalro BN, Butters MA, Leondires MP, Greer PJ, Lopresti B, Loucks TL, Berga SL: Effects of estradiol and progesterone administration on human serotonin 2A receptor binding: a PET study. Biol Psychiatry 2000; 48:854-860
133. Lu NZ, Bethea CL: Ovarian steroid regulation of 5-HT1A receptor binding and G protein activation in female monkeys. Neuropsychopharmacology 2002; 27:12-24
134. Raap DK, DonCarlos L, Garcia F, Muma NA, Wolf WA, Battaglia G, Van de Kar LD: Estrogen desensitizes 5-HT(1A) receptors and reduces levels of G(z) G(i1) and G(i3) proteins in the hypothalamus. Neuropharmacology 2000; 39:1823-1832
135. Mize AL, Poisner AM, Alper RH: Estrogens act in rat hippocampus and frontal cortex to produce rapid, receptor-mediated decreases in serotonin 5-HT1A receptor function. Neuroendocrinology 2001; 73:166-174
136. Yonkers KA, Ellison JM: Anxiety disorders in women and their pharmacological treatment, in Psychopharmacology and Women. Edited by Jensvold MF, Halbreich U, Hamilton JA. Washington DC, American Psychiatric Press, 1996, pp 261-285
137. Seeman TE, Singer BH, Rowe JW, Horwitz RI, McEwen: Price of adaptation-allostatic load and its health consequences: MacArthur studies of successful aging. Arch Intern Med 1997; 157: 2259-2268
138. Seeman TE, McEwen BS, Rowe JW, Singer BH: Allostatic load as a marker of cumulative biological risk: MacArthur studies of successful aging. Proc Natl Acad Sci USA 2001; 98:4470-4475
139. Richardson GE: The metatheory of resilience and resiliency. J Clin Psychol 2002; 58:307-321
140. Masten AS, Coatsworth JD: The development of competence in favorable and unfavorable environments. Am Psychol 1998; 53:205-220
141. Bell CC: Cultivating resiliency in youth. J Adolesc Health 2001; 29:375-381
142. Grinker R, Spiegel J: Men Under Stress. Philadelphia, Blakiston, 1945
143. Rachman SJ: Fear and Courage, 2nd ed. New York, Freeman and Co, 1992
144. Ruff G, Korchin S: Psychological responses of the Mercury astronauts to stress, in The Threat of Impending Disaster. Edited by Grosser G, Wechsler H, Greenblatt M. Cambridge, Mass, MIT Press, 1964, pp 46-57
145. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM: Neurobiology of depression. Neuron 2002; 34:13-25
146. Wise RA: Brain reward circuitry: insights from unsensed incentives. Neuron 2002; 36:229-240
147. Schultz W: Getting formal with dopamine and reward. Neuron 2002; 36:241-263
148. Martin-Soelch C, Leenders KL, Chevalley AF, Missimer J, Kunig G, Magyar S, Mino A, Schultz W: Reward mechanisms in the brain and their role in dependence: evidence from neurophysiological and neuroimaging studies. Brain Res Rev 2001; 36: 139-149
149. Kotecha SA, Oak JN, Jackson MF, Perez Y, Orser BA, Van Tol HH, McDonald JF: A D2 class dopamine receptor transactivates a receptor tyrosine kinase to inhibit NMDA receptor transmission. Neuron 2002; 35:1111-1122
150. Pliakas AM, Carlson RR, Neve RL, Konradi C, Nestler EJ, Carlezon WA Jr: Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated CREB expression in the nucleus accumbens. J Neurosci 2001; 21:7397-7403
151. Hall J, Thomas KL, Everitt BJ: Fear memory retrieval induces CREB phosphorylation and Fos expression within the amygdala. Eur J Neurosci 2001; 13:1453-1458
152. Josselyn SA, Shi CJ, Carlezon WA Jr, Neve RL, Nestler EJ, Damis M: Long-term memory is facilitated by CREB overexpression in the amygdala. J Neurosci 2001; 21:2402-2412
153. Lenox RH, Gould TD, Manji HK: Endophenotypes in bipolar disorder. Am J Med Genet 2002; 114:391-406
154. Tremblay LK, Naranjo CA, Cardenas L, Herrmann N, Busto UE: Probing brain reward system function in major depressive disorder: altered response to dextroamphetamine. Arch Gen Psychiatry 2002; 59:409-416
155. Cardenas L, Tremblay LK, Naranjo CA, Herrmann N, Zack M, Busto UE: Brain reward system activity in major depression and comorbid nicotine dependence. J Pharmacol Exp Ther 2002; 302:1265-1271
156. Blair HT, Schafe GE, Bauer EP, Rodrigues SM, LeDoux JE: Synaptic plasticity in the lateral amygdala: a cellular hypothesis of fear conditioning. Learn Mem 2001; 8:229-242
157. LeDoux JE: Emotion circuits in the brain. Annu Rev Neurosci 2000; 23:155-184
158. Schafe GE, Nader K, Blair HT, LeDoux JE: Memory consolidation of Pavlovian fear conditioning: a cellular and molecular perspective. Trends Neurosci 2001; 24:540-546
159. Shumyatsky G, Tsvetkov E, Malleret G, Vronskaya S, Horton M, Hampton L, Battey JF, Dulac C, Kandel ER, Bolshakov VY: Identification of a signaling network in lateral nucleus of amygdala important for inhibiting memory specifically related to learned fear. Cell 2002; 111:905-918
160. Walker DL, Davis M: Involvement of NMDA receptors within the amygdala in short versus long-term memory for fear conditioning as assessed with fear-potentiated startle. Behav Neurosci 2000; 114:1019-1033
161. Rodrigues SM, Schafe GE, LeDoux JE: Intra-amygdala blockade of the NR2B subunit of the NMDA receptor disrupts the acquisition but not the expression of fear conditioning. J Neurosci 2001; 21:6889-6896
162. Grillon C: Associative learning deficits increase symptoms of anxiety in humans. Biol Psychiatry 2002; 51:851-858
163. Bauer EP, Schafe GE, LeDoux JE: NMDA receptors and L-type voltage-gated calcium channels contribute to long-term potentiation and different components of fear memory formation in the lateral amygdala. J Neurosci 2002; 22:5239-5249
164. McGaugh JL: Memory consolidation and the amygdala: a systems perspective. Trends Neurosci 2002; 25:456-461
165. Killcross S, Robbins TW, Everitt BJ: Different types of fear-conditioned behavior mediated by separate nuclei within amygdala. Nature 1997; 388:377-380
166. Wilensky AE, Schafe GE, LeDoux JE: The amygdala modulates memory consolidation of fear-motivated inhibitory avoidance learning but not classical fear conditioning. J Neurosci 2000; 20:7059-7066
167. McIntyre CK, Hatfield T, McGaugh JL: Amygdala norepinephrine levels after training predict inhibitory avoidance retention performance in rats. Eur J Neurosci 2002; 16:1223-1226
168. McGaugh JL, Roozendaal B: Role of adrenal stress hormones in forming
169. Roozendaal B, Brunson KL, Holloway BL, McGaugh JL, Baram TZ: Involvement of stress-released corticotropin-releasing hormone in the basolateral amygdala in regulating memory consolidation. Proc Natl Acad Sci USA 2002; 99:13908-13913
170. Roesler R, Roozendaal B, McGaugh JL: Basolateral amygdala lesions block the memory-enhancing effect of 8-Br-cAMP infused into the entorhinal cortex of rats after training. Eur J Neurosci 2002; 15:905-910
171. Debiec J, LeDoux JE, Nader K: Cellular and systems reconsolidation in the hippocampus. Neuron 2002; 36:527-538
172. Milekic MH, Alberini CM: Temporally graded requirement for protein synthesis following memory reactivation. Neuron 2002; 36:521-525
173. Myers KM, Davis M: Systems-level reconsolidation: re-engagement of the hippocampus with memory reactivation. Neuron 2002; 36:340-343
174. Przybyslawski J, Roullet P, Sara SJ: Attenuation of emotional and nonemotional memories after their reactivation: role of β adrenergic receptors. J Neurosci 1999; 19:6623-6628
175. Sara SJ: Retrieval and reconsolidation: toward a neurobiology of remembering. Learn Mem 2000; 7:73-84
176. Nader K, Schafe GE, LeDoux JE: Fear memories require protein synthesis in the amygdala for reconsolidation after retrieval. Nature 2000; 406:722-726
177. Kida S, Josselyn SA, de Ortiz SP, Kogan JH, Chevere I, Masushige S, Silva AJ: CREB required for the stability of new and reactivated fear memories. Nat Neurosci 2002; 4:348-355
178. Przybyslawski J, Sara SJ: Reconsolidation of memory after its reactivation. Behav Brain Res 1997; 84:241-246
179. Myers KM, Davis M: Behavioral and neural analysis of extinction. Neuron 2002; 36:567-584
180. Cain CK, Blouin AM, Barad MG: L-type voltage-gated calcium channels are required for extinction, but not for acquisition or expression, of conditional fear in mice. J Neurosci 2002; 22: 9113-9121
181. McGaugh JL, Castellano C, Brioni J: Picrotoxin enhances latent extinction of conditioned fear. Behav Neurosci 1990; 104:264-267
182. Willick ML, Kokkinidis L: Cocaine enhances the expression of fear-potentiated startle: evaluation of state-dependent extinction and the shock-sensitization of acoustic startle. Behav Neurosci 1995; 109:929-938
183. Quirk GJ, Russo GK, Barron JL, Lebron K: The role of ventromedial prefrontal cortex in the recovery of extinguished fear. J Neurosci 2000; 20:6225-6231
184. Morgan MA, Romanski LM, LeDoux JE: Extinction of emotional learning: contribution of medial prefrontal cortex. Neurosci Lett 1993; 163:109-113
185. Milad MR, Quirk GJ: Neurons in medial prefrontal cortex signal memory for fear extinction. Nature 2002; 420:70-74
186. Royer S, Martina M, Pare D: Bistable behavior of inhibitory neurons controlling impulse traffic through the amygdala: role of a slowly deinactivating K+ current. J Neurosci 2000; 20: 9034-9039
187. Herry C, Garcia R: Prefrontal cortex long-term potentiation but not long-term depression is associated with maintenance of extinction of learned fear in mice. J Neurosci 2002; 22:577-583
188. Bremner JD, Staib LH, Kaloupek D, Southwick SM, Soufer R, Charney DS: Neural correlates of exposure to traumatic pictures and sound in Vietnam combat veterans with and without posttraumatic stress disorder: a positron emission tomography study. Biol Psychiatry 1999; 45:806-816
189. Davis M: The role of NMDA receptors and MAP kinase in the amygdala in extinction of fear: clinical implications for exposure therapy. Eur J Neurosci 2002; 16:395-398
190. Young LJ: The neurobiology of social recognition, approach, and avoidance. Biol Psychiatry 2002; 51:18-26
191. Ferguson JN, Young LJ, Hearn EF, Insel TR, Winslow JT: Social amnesia in mice lacking the oxytocin gene. Nat Genet 2000; 25:284-288
192. Ferguson JN, Aldag JM, Insel TR, Young LJ: Oxytocin in the medial amygdala is essential for social recognition in the mouse. J Neurosci 2001; 21:8278-8285
193. Carter CS, Getz LL: Monogamy and the prairie vole. Sci Am 1993; 268:100-106
194. Shapiro LE, Dewsbury DA: Differences in affiliative behavior, pair bonding, and vaginal cytology in two species of vole (Microtus Ochrogaster and M montanus). J Comp Psychol 1990; 104:268-274
195. Insel TR, Wang Z, Ferris CF: Patterns of brain vasopressin receptor distribution associated with social organization in microtine rodents. J Neurosci 1994; 14:5381-5392
196. Young LJ, Winslow JT, Nilsen R, Insel TR: Species differences in V1a receptor gene expression in monogamous and non-monogamous voles: behavioral consequences. Behav Neurosci 1997; 111: 599-605
197. McBride WJ, Murphy JM, Ikemoto S: Localization of brain reinforcement mechanisms: intracranial self-administration and intracranial place-conditioning studies. Behav Brain Res 1999; 101:129-152
198. Rilling JK, Gutman DA, Zeh TR, Pagnoni G, Berns GS, Kilts CD: A neural basis for social cooperation. Neuron 2002; 35:395-405
199. Dolan RJ: Emotion, cognition, and behavior. Science 2002; 298:1191-1194
200. True WR, Rice J, Eisen SA, Heath AC, Goldberg J, Lyons MJ, Nowak J: A twin study of genetic and environmental contributions to liability for posttraumatic stress symptoms. Arch Gen Psychiatry 1993; 50:257-264
201. Comings DE, Muhleman D, Gysin R: Dopamine D2 receptor (DRD2) gene and susceptibility to posttraumatic stress disorder: a study and replication. Biol Psychiatry 1996; 40:368-372
202. Gelernter J, Southwick S, Goodson S, Morgan A, Nagy L, Charney DS: No association between D2 dopamine receptor (DRD2) "A" system alleles or DRD2 haplotypes, and posttraumatic stress disorder. Biol Psychiatry 1999; 45:620-625
203. Segman RH, Cooper-Kazaz R, Macciardi F, Goltser T, Halfon Y, Dobroborski T, Shalev AY: Association between the dopamine transporter gene and posttraumatic stress disorder. Mol Psychiatry 2002; 7:903-907
204. Bremner JD, Randall P, Scott TM, Bronen RA, Seibyl JP, Southwick SM, Delaney RC, McCarthy G, Charney DS, Innis RB: MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder. Am J Psychiatry 1995; 152:973-981
205. Bremner JD, Randall P, Vermetten E, Staib L, Bronen RA, Mazure C, Capelli S, McCarthy G, Innis RB, Charney DS: Magnetic resonance imaging-based measurements of hippocampal volume in posttraumatic stress disorder related to childhood physical and sexual abuse - a preliminary report. Biol Psychiatry 1997; 41:23-32
206. Gurvits TV, Shenton ME, Hokama H, Ohta H, Lasko NB, Gilbertson MW, Orr SP, Kikinis R, Jolesz FA, McCarley RW, Pitman RK: Magnetic resonance imaging study of hippocampal volume in chronic, combat-related posttraumatic stress disorder. Biol Psychiatry 1996; 40:1091-1099
207. Gilbertson MW, Shenton ME, Ciszewski A, Kasai K, Lasko NB, Orr SP, Pitman RK: Smaller hippocampal volume predicts pathologic vulnerability to psychological trauma. Nat Neurosci 2002, 5:1242-1247
208. DeRijk RH, Schaaf M, de Kloet ER: Glucocorticoid receptor variants: clinical implications. J Steroid Biochem Mol Biol 2002; 81: 103-122
209. Small KM, Wagoner LE, Levin AM, Kardia SLR, Liggett ST: Synergistic polymorphisms of β1 and α2c adrenergic receptors and the risk of congestive heart failure. N Engl J Med 2002; 347: 1135-1142
210. Kallio J, Pesonen U, Kaipio K, Karvonen MK, Jaakkola U, Heinonen OJ, Uusitupa MI, Koulu M: Altered intracellular processing and release of neuropeptide Y due to leucine 7 to proline 7 polymorphism in the signal peptide of preproneuropeptide Y in humans. FASEB J 2001; 15:1242-1244
211. Goddard AW, Mason GF, Rothman DL, Behar KL, Petroff OA, Charney DS, Krystal JH: Reductions in occipital cortex GABA levels in panic disorder. Arch Gen Psychiatry 2001; 58:556-561
212. Ishikawa-Brush Y, Powell JF, Bolton P, Miller AP, Francis F, Willard HF, Lehrach H, Monaco AP: Autism and multiple exostoses associated with an X-8 translocation occurring within the GRPR gene and 3′ to the SDC2 gene. Hum Mol Genet 1997; 6:1241-1250
213. Insel TR, Young LJ: The neurobiology of attachment. Nat Rev Neurosci 2001; 2:129-136
214. Hariri AR, Mattay VS, Tessitore A, Kolachana B, Fera F, Goldman D, Egan MF, Weinberger DR: Serotonin transporter genetic variation and the response of the human amygdala. Science 2002; 297:400-403
215. Garpenstrand H, Annas P, Ekblom J, Oreland L, Fredrikson M: Human fear conditioning is related to dopaminergic and serotonergic biological markers. Behav Neurosci 2001; 115:358-364
216. Holmes A, Yang RJ, Murphy DL, Crawley JN: Evaluation of anti-depressant-related behavioral responses to mice lacking the serotonin transporter. Neuropsychopharmacology 2002; 27: 914-923
217. Plato, vol II: Laches, Protogoras, Meno Euth Demus. Washington, DC, Howard University Press, 1924, pp 1-85
218. Rutter M: The interplay of nature, nurture, and developmental influences. Arch Gen Psychiatry 2002, 59:996-1000
219. Masten AS: Resilience processes in development. Am Psychol 2001;227-238